Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
December-2020 Volume 22 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
December-2020 Volume 22 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Role of cofilin‑1 in arsenic trioxide‑induced apoptosis of NB4‑R1 cells

  • Authors:
    • Huachao Zhu
    • Xiaoyan Zheng
    • Hui Feng
    • Wenjuan Wang
    • Xiaoning Wang
    • Miaojing Li
    • Huaiyu Wang
    • Jing Zhao
    • Pengcheng He
  • View Affiliations / Copyright

    Affiliations: Department of Hematology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China
    Copyright: © Zhu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 4645-4654
    |
    Published online on: October 8, 2020
       https://doi.org/10.3892/mmr.2020.11570
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

All‑trans retinoic acid (ATRA) and arsenic trioxide (As2O3) are currently first‑line treatments for acute promyelocytic leukemia (APL). However, a number of patients with APL are resistant to ATRA but still sensitive to As2O3, and the underlying mechanisms of this remain unclear. In the present study, two‑dimensional gel electrophoresis, mass spectrometry and other proteomic methods were applied to screen and identify the differentially expressed proteins between the retinoic acid‑sensitive cell lines and drug‑resistant cell lines. The results demonstrated that in retinoic acid‑resistant NB4‑R1 cells, the protein expression of cofilin‑1 was markedly increased compared with that in the drug‑sensitive NB4 cells. Subsequently, the effects of cofilin‑1 on As2O3‑induced apoptosis in NB4‑R1 cells were further investigated. The results revealed that cell viability was markedly suppressed and apoptosis was increased in the As2O3‑treated NB4‑R1 cells, with increased expression levels of cleaved‑poly (ADP‑ribose) polymerase and cleaved‑caspase 12. Cofilin‑1 expression was significantly decreased at both the mRNA and protein levels in the As2O3‑treated group compared with the control. Western blotting further revealed that As2O3 treatment decreased the cytoplasmic cofilin‑1 level but increased its expression in the mitochondrion. However, the opposite effects of As2O3 on the cytochrome C distribution were found in NB4‑R1 cells. This suggested that As2O3 can induce the transfer of cofilin‑1 from the cytoplasm to mitochondria and trigger the release of mitochondrial cytochrome C in NB4‑R1 cells. Moreover, cofilin‑1 knockdown by its specific short hairpin RNA significantly suppressed As2O3‑induced NB4‑R1 cell apoptosis and inhibited the release of mitochondrial cytochrome C. Whereas, overexpression of cofilin‑1 using a plasmid vector carrying cofilin‑1 increased the release of cytochrome C into the cytoplasm from the mitochondria in As2O3‑treated NB4‑R1 cells. In conclusion, cofilin‑1 played a role in As2O3‑induced NB4‑R1 cell apoptosis and it might be a novel target for APL treatment.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Park JH, Qiao B, Panageas KS, Schymura MJ, Jurcic JG, Rosenblat TL, Altman JK, Douer D, Rowe JM and Tallman MS: Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid. Blood. 118:1248–1254. 2011. View Article : Google Scholar : PubMed/NCBI

2 

Grignani F, Ferrucci PF, Testa U, Talamo G, Fagioli M, Alcalay M, Mencarelli A, Grignani F, Peschle C, Nicoletti I, et al: The acute promyelocytic leukemia-specific PML-RAR alpha fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell. 74:423–431. 1993. View Article : Google Scholar : PubMed/NCBI

3 

Yang L, Chai W, Wang Y, Cao L, Xie M, Yang M, Kang R and Yu Y: Reactive oxygen species regulate the differentiation of acute promyelocytic leukemia cells through HMGB1-mediated autophagy. Am J Cancer Res. 5:714–725. 2015.PubMed/NCBI

4 

Bassi SC and Rego EM: Molecular basis for the diagnosis and treatment of acute promyelocytic leukemia. Rev Bras Hematol Hemoter. 34:134–139. 2012. View Article : Google Scholar : PubMed/NCBI

5 

Sanz MA, Fenaux P, Tallman MS, Estey EH, Löwenberg B, Naoe T, Lengfelder E, Döhner H, Burnett AK, Chen SJ, et al: Management of acute promyelocytic leukemia: Updated recommendations from an expert panel of the European LeukemiaNet. Blood. 133:1630–1643. 2019. View Article : Google Scholar : PubMed/NCBI

6 

Lo-Coco F, Avvisati G, Vignetti M, Thiede C, Orlando SM, Iacobelli S, Ferrara F, Fazi P, Cicconi L, Di Bona E, et al: Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. N Engl J Med. 369:111–121. 2013. View Article : Google Scholar : PubMed/NCBI

7 

Burnett AK, Russell NH, Hills RK, Bowen D, Kell J, Knapper S, Morgan YG, Lok J, Grech A, Jones G, et al: Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): Results of a randomised, controlled, phase 3 trial. Lancet Oncol. 16:1295–1305. 2015. View Article : Google Scholar : PubMed/NCBI

8 

Zhang XW, Yan XJ, Zhou ZR, Yang FF, Wu ZY, Sun HB, Liang WX, Song AX, Lallemand-Breitenbach V, Jeanne M, et al: Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML. Science. 328:240–243. 2010. View Article : Google Scholar : PubMed/NCBI

9 

Esnault C, Rahmé R, Rice KL, Berthier C, Gaillard C, Quentin S, Maubert AL, Kogan S and de Thé H: FLT3-ITD impedes retinoic acid, but not arsenic, responses in murine acute promyelocytic leukemias. Blood. 133:1495–1506. 2019. View Article : Google Scholar : PubMed/NCBI

10 

Goto E, Tomita A, Hayakawa F, Atsumi A, Kiyoi H and Naoe T: Missense mutations in PML-RARA are critical for the lack of responsiveness to arsenic trioxide treatment. Blood. 118:1600–1609. 2011. View Article : Google Scholar : PubMed/NCBI

11 

Zhu HH, Qin YZ and Huang XJ: Resistance to arsenic therapy in acute promyelocytic leukemia. N Engl J Med. 370:1864–1866. 2014. View Article : Google Scholar : PubMed/NCBI

12 

Lehmann-Che J, Bally C and de Thé H: Resistance to therapy in acute promyelocytic leukemia. N Engl J Med. 371:1170–1172. 2014. View Article : Google Scholar : PubMed/NCBI

13 

Ozpolat B, Mehta K and Lopez-Berestein G: Regulation of a highly specific retinoic acid-4-hydroxylase (CYP26A1) enzyme and all-trans-retinoic acid metabolism in human intestinal, liver, endothelial, and acute promyelocytic leukemia cells. Leuk Lymphoma. 46:1497–1506. 2005. View Article : Google Scholar : PubMed/NCBI

14 

de Thé H and Chen Z: Acute promyelocytic leukaemia: Novel insights into the mechanisms of cure. Nat Rev Cancer. 10:775–783. 2010. View Article : Google Scholar : PubMed/NCBI

15 

Liang C, Ding M, Weng XQ, Sheng Y, Wu J, Li ZY and Cai X: Combination of enzastaurin and ATRA exerts dose-dependent dual effects on ATRA-resistant acute promyelocytic leukemia cells. Am J Cancer Res. 9:906–926. 2019.PubMed/NCBI

16 

Chua BT, Volbracht C, Tan KO, Li R, Yu VC and Li P: Mitochondrial translocation of cofilin is an early step in apoptosis induction. Nat Cell Biol. 5:1083–1089. 2003. View Article : Google Scholar : PubMed/NCBI

17 

Rehklau K, Gurniak CB, Conrad M, Friauf E, Ott M and Rust MB: ADF/cofilin proteins translocate to mitochondria during apoptosis but are not generally required for cell death signaling. Cell Death Differ. 19:958–967. 2012. View Article : Google Scholar : PubMed/NCBI

18 

Satoh M, Takano S, Sogawa K, Noda K, Yoshitomi H, Ishibashi M, Mogushi K, Takizawa H, Otsuka M, Shimizu H, et al: Immune-complex level of cofilin-1 in sera is associated with cancer progression and poor prognosis in pancreatic cancer. Cancer Sci. 108:795–803. 2017. View Article : Google Scholar : PubMed/NCBI

19 

Tahtamouni LH, Shaw AE, Hasan MH, Yasin SR and Bamburg JR: Non-overlapping activities of ADF and cofilin-1 during the migration of metastatic breast tumor cells. BMC Cell Biol. 14:452013. View Article : Google Scholar : PubMed/NCBI

20 

Wang C, Zhou GL, Vedantam S, Li P and Field J: Mitochondrial shuttling of CAP1 promotes actin- and cofilin-dependent apoptosis. J Cell Sci. 121:2913–2920. 2008. View Article : Google Scholar : PubMed/NCBI

21 

Blough ER, Rennie ER, Zhang F and Reiser PJ: Enhanced electrophoretic separation and resolution of myosin heavy chains in mammalian and avian skeletal muscles. Anal Biochem. 233:31–35. 1996. View Article : Google Scholar : PubMed/NCBI

22 

Barber RD, Harmer DW, Coleman RA and Clark BJ: GAPDH as a housekeeping gene: Analysis of GAPDH mRNA expression in a panel of 72 human tissues. Physiol Genomics. 21:389–395. 2005. View Article : Google Scholar : PubMed/NCBI

23 

Barrientos A, Barros MH, Valnot I, Rötig A, Rustin P and Tzagoloff A: Cytochrome oxidase in health and disease. Gene. 286:53–63. 2002. View Article : Google Scholar : PubMed/NCBI

24 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

25 

Villanueva J, Lawlor K, Toledo-Crow R and Tempst P: Automated serum peptide profiling. Nat Protoc. 1:880–891. 2006. View Article : Google Scholar : PubMed/NCBI

26 

Strupat K: Molecular weight determination of peptides and proteins by ESI and MALDI. Methods Enzymol. 405:1–36. 2005. View Article : Google Scholar : PubMed/NCBI

27 

McCulloch D, Brown C and Iland H: Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: Current perspectives. Onco Targets Ther. 10:1585–1601. 2017. View Article : Google Scholar : PubMed/NCBI

28 

Wang L, Xiao H, Zhang X, Liao W, Fu S and Huang H: Restoration of CCAAT enhancer binding protein α P42 induces myeloid differentiation and overcomes all-trans retinoic acid resistance in human acute promyelocytic leukemia NB4-R1 cells. Int J Oncol. 47:1685–1695. 2015. View Article : Google Scholar : PubMed/NCBI

29 

Bruel A, Benoit G, De Nay D, Brown S and Lanotte M: Distinct apoptotic responses in maturation sensitive and resistant t(15;17) acute promyelocytic leukemia NB4 cells. 9-cis retinoic acid induces apoptosis independent of maturation and Bcl-2 expression. Leukemia. 9:1173–1184. 1995.PubMed/NCBI

30 

Becker M, De Bastiani MA, Müller CB, Markoski MM, Castro MA and Klamt F: High cofilin-1 levels correlate with cisplatin resistance in lung adenocarcinomas. Tumour Biol. 35:1233–1238. 2014. View Article : Google Scholar : PubMed/NCBI

31 

Liao PH, Hsu HH, Chen TS, Chen MC, Day CH, Tu CC, Lin YM, Tsai FJ, Kuo WW and Huang CY: Phosphorylation of cofilin-1 by ERK confers HDAC inhibitor resistance in hepatocellular carcinoma cells via decreased ROS-mediated mitochondria injury. Oncogene. 36:1978–1990. 2017. View Article : Google Scholar : PubMed/NCBI

32 

Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner BA and Yuan J: Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature. 403:98–103. 2000. View Article : Google Scholar : PubMed/NCBI

33 

Elena-Real CA, Díaz-Quintana A, González-Arzola K, Velázquez-Campoy A, Orzáez M, López-Rivas A, Gil-Caballero S, De la Rosa MÁ and Díaz-Moreno I: Cytochrome c speeds up caspase cascade activation by blocking 143-3epsilon-dependent Apaf-1 inhibition. Cell Death Dis. 9:3652018. View Article : Google Scholar : PubMed/NCBI

34 

Babbitt SE, Sutherland MC, San Francisco B, Mendez DL and Kranz RG: Mitochondrial cytochrome c biogenesis: No longer an enigma. Trends Biochem Sci. 40:446–455. 2015. View Article : Google Scholar : PubMed/NCBI

35 

Liu T, Wang F, LePochat P, Woo JA, Bukhari MZ, Hong KW, Trotter C and Kang DE: Cofilin-mediated neuronal apoptosis via p53 translocation and PLD1 regulation. Sci Rep. 7:115322017. View Article : Google Scholar : PubMed/NCBI

36 

Kang DE and Woo JA: Cofilin, a master node regulating cytoskeletal pathogenesis in Alzheimer's disease. J Alzheimers Dis. 72 (Suppl 1):S131–S144. 2019. View Article : Google Scholar : PubMed/NCBI

37 

Li GB, Cheng Q, Liu L, Zhou T, Shan CY, Hu XY, Zhou J, Liu EH, Li P and Gao N: Mitochondrial translocation of cofilin is required for allyl isothiocyanate-mediated cell death via ROCK1/PTEN/PI3K signaling pathway. Cell Commun Signal. 11:502013. View Article : Google Scholar : PubMed/NCBI

38 

Xing JS, Wang X, Lan YL, Lou JC, Ma B, Zhu T, Zhang H, Wang D, Yu Z, Yuan Z, et al: Isoalantolactone inhibits IKKβ kinase activity to interrupt the NF-κB/COX-2-mediated signaling cascade and induces apoptosis regulated by the mitochondrial translocation of cofilin in glioblastoma. Cancer Med. 8:1655–1670. 2019. View Article : Google Scholar : PubMed/NCBI

39 

Lu Z, Jia X, Chen Y, Han X, Chen F, Tian S, Su X, Li Z, Zhao J, Zhang X, et al: Identification and characterization of key charged residues in the cofilin protein involved in azole susceptibility, apoptosis, and virulence of Aspergillus fumigatus. Antimicrob Agents Chemother. 62:e01659–17. 2018. View Article : Google Scholar : PubMed/NCBI

40 

Xiao P, Ma T, Zhou C, Xu Y, Liu Y and Zhang H: Anticancer effect of docetaxel induces apoptosis of prostate cancer via the cofilin-1 and paxillin signaling pathway. Mol Med Rep. 13:4079–4084. 2016. View Article : Google Scholar : PubMed/NCBI

41 

Dong X, Ma N, Liu M and Liu Z: Effects of As2O3 nanoparticles on cell growth and apoptosis of NB4 cells. Exp Ther Med. 10:1271–1276. 2015. View Article : Google Scholar : PubMed/NCBI

42 

Chelbi-alix MK, Bobé P, Benoit G, Canova A and Pine R: Arsenic enhances the activation of Stat1 by interferon gamma leading to synergistic expression of IRF-1. Oncogene. 22:9121–9130. 2003. View Article : Google Scholar : PubMed/NCBI

43 

de Thé H, Pandolfi PP and Chen Z: Acute promyelocytic leukemia: A paradigm for oncoprotein-targeted cure. Cancer Cell. 32:552–560. 2017. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Zhu H, Zheng X, Feng H, Wang W, Wang X, Li M, Wang H, Zhao J and He P: Role of cofilin‑1 in arsenic trioxide‑induced apoptosis of NB4‑R1 cells. Mol Med Rep 22: 4645-4654, 2020.
APA
Zhu, H., Zheng, X., Feng, H., Wang, W., Wang, X., Li, M. ... He, P. (2020). Role of cofilin‑1 in arsenic trioxide‑induced apoptosis of NB4‑R1 cells. Molecular Medicine Reports, 22, 4645-4654. https://doi.org/10.3892/mmr.2020.11570
MLA
Zhu, H., Zheng, X., Feng, H., Wang, W., Wang, X., Li, M., Wang, H., Zhao, J., He, P."Role of cofilin‑1 in arsenic trioxide‑induced apoptosis of NB4‑R1 cells". Molecular Medicine Reports 22.6 (2020): 4645-4654.
Chicago
Zhu, H., Zheng, X., Feng, H., Wang, W., Wang, X., Li, M., Wang, H., Zhao, J., He, P."Role of cofilin‑1 in arsenic trioxide‑induced apoptosis of NB4‑R1 cells". Molecular Medicine Reports 22, no. 6 (2020): 4645-4654. https://doi.org/10.3892/mmr.2020.11570
Copy and paste a formatted citation
x
Spandidos Publications style
Zhu H, Zheng X, Feng H, Wang W, Wang X, Li M, Wang H, Zhao J and He P: Role of cofilin‑1 in arsenic trioxide‑induced apoptosis of NB4‑R1 cells. Mol Med Rep 22: 4645-4654, 2020.
APA
Zhu, H., Zheng, X., Feng, H., Wang, W., Wang, X., Li, M. ... He, P. (2020). Role of cofilin‑1 in arsenic trioxide‑induced apoptosis of NB4‑R1 cells. Molecular Medicine Reports, 22, 4645-4654. https://doi.org/10.3892/mmr.2020.11570
MLA
Zhu, H., Zheng, X., Feng, H., Wang, W., Wang, X., Li, M., Wang, H., Zhao, J., He, P."Role of cofilin‑1 in arsenic trioxide‑induced apoptosis of NB4‑R1 cells". Molecular Medicine Reports 22.6 (2020): 4645-4654.
Chicago
Zhu, H., Zheng, X., Feng, H., Wang, W., Wang, X., Li, M., Wang, H., Zhao, J., He, P."Role of cofilin‑1 in arsenic trioxide‑induced apoptosis of NB4‑R1 cells". Molecular Medicine Reports 22, no. 6 (2020): 4645-4654. https://doi.org/10.3892/mmr.2020.11570
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team